Anticarcinogenic Effect and Enhancement of Metastatic Potential of BALB/c 3T3 Cells by Ginsenoside Rh2
Open Access
- 1 November 2001
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 92 (11), 1184-1189
- https://doi.org/10.1111/j.1349-7006.2001.tb02138.x
Abstract
It has been reported that ginsenoside Rh2, a purified ginseng saponin with a dammarane skeleton, has anticarcinogenic effects on mammalian cells. To determine the significance of these effects on multistage carcinogenesis, we utilized the BALB/c 3T3 cell system. In an in vitro two–stage neoplas–tic transformation assay, the initiating activity of 3–methylcholanthrene (3–MCA) was suppressed by Rh2 (>lxlO–5M) in both BALB/c 3T3 A31–1–1 cells and the more carcinogen–susceptible variant A31–1–13 cells. The suppressive effects in this concentration range were thought to be caused by suppression of DNA replication via indirect Cdk2 inhibition. On the other hand, the promotion steps of both the target cells were not affected by Rh2 even if the transformation frequency was enhanced by a tumor promoter, 12–O–tetradecanoylphorbol–13–acetate (TPA). To examine the other effects of Rh2 on carcinogenesis, we turned our attention to the metastatic phenotype. Using metastatic src–transformed A31–1–1 cells, we found that Rh2 augmented the metastatic potential in an experimental metastasis assay. These data indicate that Rh2 has diverse effects on the expression of the transformed phenotype in BALB/c 3T3 cells, but support the idea that growth suppression is likely to be a major mechanism of the anticarcinogenic effects of Rh2.Keywords
This publication has 37 references indexed in Scilit:
- Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-XL-independent pathwayLife Sciences, 1999
- Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer CellsJapanese Journal of Cancer Research, 1998
- G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cellsLife Sciences, 1996
- In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cellsEuropean Journal of Cancer, 1996
- Ginsenosides activate DNA polymerase δ from bovine placentaLife Sciences, 1995
- Elongation factor-1α gene determines susceptibility to transformationNature, 1992
- Analysis of cell variants showing differential susceptibilities to radiation‐ or chemical‐induced neoplastic transformation: Differences in their responses to growth factorsJournal of Cellular Physiology, 1989
- Ultrastructural studies of Morris hepatoma cells reversely transformed by ginsenosidesCellular and Molecular Life Sciences, 1979
- Induction of phenotypic reverse transformation by ginsenosides in cultured Morris hepatoma cellsEuropean Journal of Cancer (1965), 1979
- Requirement for cell replication in the fixation and expression of the transformed state in mouse cells treated with 4‐nitroquinoline‐1‐oxideInternational Journal of Cancer, 1974